GlassScriptPhysician profile
Charles W Yowell
NPI 1447213467
$5,069.89
in general payments reported to CMS, 2019-2025
44 companies · $1,405 in 2025
The $1,405 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $326 · 2021: $264 · 2022: $858 · 2023: $1,254 · 2024: $700 · 2025: $1,405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,352 · Travel and Lodging: $7.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,351.87 |
| Travel and Lodging | $7.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $595.31 | 2021-2024 | Axonics |
| Sumitomo Pharma America, INC. | $475.67 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $453.20 | 2019-2025 | Axonics, Ams 700, Lithovue |
| Medtronic, INC. | $412.51 | 2021-2025 | Interstim |
| Astellas Pharma US INC | $395.51 | 2019-2024 | Veozah, Myrbetriq, Xtandi |
| Pfizer INC. | $283.13 | 2019-2025 | |
| Janssen Biotech, INC. | $280.58 | 2020-2025 | Erleada, Akeega |
| Teleflex LLC | $230.56 | 2023-2025 | Urolift, Barrigel |
| Procept Biorobotics Corporation | $226.62 | 2022-2025 | |
| Coloplast Corp | $167.66 | 2019-2025 | Speedicath |
| Endo Pharmaceuticals INC. | $140.34 | 2019-2023 | Aveed, Xiaflex, Edex |
| 180 Medical, INC. | $134.77 | 2019-2024 | Gentlecath |
| Abbvie INC. | $98.76 | 2022-2025 | |
| Healthtronics Stone Solutions, LLC | $87.05 | 2019 | |
| Ferring Pharmaceuticals INC. | $86.92 | 2024-2025 | Adstiladrin |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $78.73 | 2022 | |
| Neotract INC. | $68.26 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $62.42 | 2025 | Prolaris |
| Ethicon US, LLC | $57.46 | 2021-2023 | Certus 140 |
| Myovant Sciences INC. | $54.35 | 2022 | |
| Novartis Pharmaceuticals Corporation | $52.88 | 2025 | |
| Calyxo, INC. | $50.66 | 2025 | Cvac Aspiration System |
| Becton, Dickinson and Company | $48.63 | 2025 | Purewick Female External Catheter, Bard Urinary Drainage Bag |
| Endo USA, INC. | $45.44 | 2025 | Xiaflex |
| Bayer Healthcare Pharmaceuticals INC. | $44.73 | 2025 | |
| Janssen Scientific Affairs, LLC | $44.40 | 2025 | Erleada, Pipeline |
| Tolmar, INC. | $41.92 | 2024-2025 | Eligard, Jatenzo |
| Merck Sharp & Dohme LLC | $40.13 | 2024 | Lynparza, Keytruda, Welireg |
| Edap Technomed INC | $33.91 | 2025 | |
| Photocure INC | $28.83 | 2020-2023 | Cysview |
| C. R. Bard, INC. & Subsidiaries | $26.60 | 2023 | Bard Urinary Drainage Bag |
| Blue Earth Diagnostics | $23.46 | 2023 | |
| Tempus Ai, INC | $21.52 | 2024 | Xt Cdx |
| Lsi Solutions INC | $19.32 | 2024 | Jnw Urtrac, Ti-Knot, Running Device |
| Tolmar Pharmaceuticals, INC. | $18.56 | 2020 | |
| Medtronic USA, INC. | $18.42 | 2019 | |
| Urogen Pharma, INC. | $18.25 | 2025 | |
| Azurity Pharmaceuticals, INC. | $17.01 | 2025 | Azmiro |
| Laborie Medical Technologies Corp. | $16.57 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Verity Pharmaceuticals INC. | $15.64 | 2025 | Tlando |
| Ethicon INC. | $15.06 | 2021 | |
| Allergan, INC. | $13.81 | 2019 | |
| Zyla Life Sciences, INC. | $13.20 | 2020 | |
| Amgen INC. | $11.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Yowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.